Tokyo, June 25, 2015 – Sandoz has announced the Japanese market introduction of three new products including clopidogrel, tacrolimus and pitavastatin (line extension).

Clopidogrel, a generic version of Sanofi’s Plavix®, is used for suppression of recurrence of ischemic cerebrovascular disorder. Tacrolimus, a generic version of Astellas’s PROGRAF®, is used among others to prevent organ transplant rejection (kidney, liver, heart, lung, pancreas, small intestine). Pitavastatin, a generic version of Kowa’s LIVALO®, is used for lowering cholesterol.

“We are pleased …